Market Cap 188.26M
Revenue (ttm) 80.00M
Net Income (ttm) -65.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -81.25%
Debt to Equity Ratio 0.00
Volume 455,100
Avg Vol 368,670
Day's Range N/A - N/A
Shares Out 55.21M
Stochastic %K 1%
Beta 1.02
Analysts Strong Sell
Price Target $15.67

Latest News on VYGR

Voyager Provides Update on SOD1 ALS Gene Therapy Program

Feb 11, 2025, 7:00 AM EST - 7 weeks ago

Voyager Provides Update on SOD1 ALS Gene Therapy Program


Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:07 PM EST - 5 months ago

Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript


The 'Undercovered' Dozen From June 1-6

Jun 7, 2024, 6:26 PM EDT - 10 months ago

The 'Undercovered' Dozen From June 1-6

ALNY CLOV CRSP ENVX GAM HAL LPA


3 Biotech Names Under $10 I Own

Jun 2, 2024, 10:18 AM EDT - 10 months ago

3 Biotech Names Under $10 I Own

AUPH FOLD


Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:43 AM EDT - 11 months ago

Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript